is tirzepatide a lifelong drug Tirzepitide: Next-Generation Weight Loss Solution To keep pounds off, patients

Diabetes Care 41, 258266

With regards to rhythm control strategies: Black patients are less likely to receive rhythm control therapies (whether cardioversion, medical, or invasive) and more likely to receive rate control therapy.8 Black patients have a better response to catheter ablation of atrial fibrillation compared to white patients

It helps people to feel less hungry, to feel full faster, and to stay full longer but it does so when we are actually less full. While the drugs help with long-term weight management for diabetics and those who are obese, Ozempic and Wegovy are now both being used and abused by those who need to lose just five or 10 pounds

RetatrutideMounjaro (Tirzepatide)Wegovy (Semaglutide) Mechanism Triple (GLP-1 + GIP + Glucagon)Dual (GLP-1 + GIP)Single (GLP-1) Best weight loss in trials 30.3%22.5%20.7% Trial duration 104 weeks72 weeks72 weeks UK approval Not yetYes (Mounjaro)Yes (Wegovy) Injection frequency Once weeklyOnce weeklyOnce weekly One important caveat: the 30.3% figure comes from a 104-week trial, while the Mounjaro and Wegovy results are from 72-week trials

To date, there have been no observed cases of serious side effects in semaglutide users

No large-scale studies have directly evaluated semaglutide as a GERD treatment